China, Egypt mark joint production of 1M COVID-19 vaccine doses in Egypt

EGYPT – Chinese State Councilor and Foreign Minister Wang Yi and his Egyptian counterpart Sameh Shoukry commemorated a ceremony marking the joint production of 1 million doses of COVID-19 vaccine in Egypt. After China and Egypt inked a letter of intent for cooperation on COVID-19 vaccine production in December 2020, a Chinese company signed an agreement with an Egyptian firm and sent technical teams to Egypt to facilitate the local production of the vaccine. Only half a year after the signing of the agreement, the Chinese vaccine was officially put…

Read More

WHO urges China to be more cooperative as its probes to identify COVID-19 origin

WORLD – World Health Organization (WHO) is planning to rollout its next investigation phase to probe the origin of COVID-19 and it has urged China to be more cooperative during this next phase in reference to providing more raw data. The WHO chief, Tedros, said that the organization is laying the groundwork for moving forward with fresh investigations into where Covid-19 came from following a previous attempt that saw WHO send a team of international experts who expressed lack of data as a hinderance into the investigation. Tedros also added…

Read More

Biogen signs collaborative agreement with Innocare to use orelabrutinib as potential therapy for multiple sclerosis

WORLD – Biogen and Innocare, a biopharmaceutical company rooted in China, have signed a license and a collaboration agreement for the use of Orelabrutinib that could potentially be used to treat multiple sclerosis. Under the terms of the agreement, Biogen will have exclusive rights to orelabrutinib in the field of MS worldwide and certain autoimmune diseases outside of China, while Innocare will retain exclusive worldwide rights to orelabrutinib in the field of oncology and certain autoimmune diseases in China. InnoCare will receive a US$125M upfront payment and is eligible to…

Read More

China’s Sinopharm vaccine gaining popularity in Africa, as Tunisia grants approval

TUNISIA – Tunisian Ministry of Health has announced that China’s Sinopharm COVID-19 vaccine has been officially approved for marketing in the country. “The Ministry of Health has granted an exceptional and provisional marketing authorization in the Tunisian market for China’s Sinopharm COVID-19 vaccine,” said a ministry statement. The marketing authorization was granted after the issue was evaluated by the specialized committee in the field of virology, toxicology and the Technical Committee for Pharmaceutical Specialties. Since the start of the national vaccination campaign against the coronavirus on March 13, a total…

Read More